- 1. Злоякісні новоутворення молочної залози (2024) 2024 рік — уточнена інформація. Рак в Україні, 2022–2023. Захворюваність, смертність, показники діяльності онкологічної служби. Бюлетень національного канцер-реєстру України № 25. Київ. http://www.ncru.inf.ua/publications/BULL_25/index.htm.
- 2. Katsika L., Boureka E., Kalogiannidis I. et al. (2024) Screening for Breast Cancer: A Comparative Review of Guidelines. Life, 14(6): 777. DOI.org/10.3390/life14060777.
- 3. WHO (2014) WHO Guidelines Approved by the Guidelines Review Committee. WHO Position Paper on Mammography Screening. Switzerland, Geneva.
- 4. Siu A.L. Screening for Breast Cancer: U.S. (2016) Preventive Services Task Force Recommendation Statement. Ann. Intern. Med., 164(4): 279–296. doi.org/10.7326/m15-2886.
- 5. Oeffinger K.C., Fontham E.T., Etzioni R. et al. (2015) Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society, 314(15): 1599–1614. doi.org/10.1001/jama.2015.12783.
- 6. Bevers T.B., Niell B.L., Baker J.L. et al. (2023) NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J. Natl. Compr. Cancer Netw., 21(9): 900–909. DOI: 10.6004/jnccn.2023.0046.
- 7. Committee on Practice Bulletins — Gynecology. Practice Bulletin Number 179 (2017) Breast Cancer Risk Assessment and Screening in Average-Risk Women. Obstet. Gynecol., 130: e1–e16.
- 8. Surgeons TASoB (2019) Position Statement on Screening Mammography. http://www.breastsurgeons.org/docs/statements/Position-Statement-on-Screening-Mammography.pdf.
- 9. Monticciolo D.L., Newell M.S., Hendrick R.E. et al. (2017) Breast Cancer Screening for Average-Risk Women: Recommendations from the ACR Commission on Breast Imaging. J. Am. Coll. Radiol., 14(9): 1137–1143. doi.org/10.1016/j.jacr.2017.06.001.
- 10. Beck A., Mls B.S. (2017) Breast Cancer Screening: Protocol for an Evidence Report to Inform an Update of the Canadian Task Force on Preventive Health Care 2011 Guidelines. canadiantaskforce.ca/wp-content/uploads/2017/09/BCU-protocol-14Mar2017-FINAL.pdf.
- 11. Schünemann H.J., Lerda D., Quinn C. et al. (2020) Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines. Ann. Intern. Med., 172(1): 46–56. doi.org/10.7326/m19-2125.
- 12. Cardoso F., Kyriakides S., Ohno S. et al. (2012) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 30(8): 1194–1220. DOI: 10.1093/annonc/mdz173.
- 13. Harris M., Bennett J., Del Mar C.B. et al. (2009) Guidelines for Preventive Activities in General Practice. The Royal Australian College of General Practitioners. Sydney.
- 14. Hamashima C., Hamashima C.C., Hattori M. et al. (2016) The Japanese Guidelines for Breast Cancer Screening. Jpn. J. Clin. Oncol., 46(5): 482–492.
- 15. Bancej C., Decker K., Chiarelli A. et al. (2003) Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J. Med. Screen., 10(1): 16–21. DOI: 10.1258/096914103321610761.
- 16. Bobo J.K., Lee N.C., Thames S.F. (2000) Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J. Natl. Cancer Inst., 92(12): 971–976. DOI: 10.1093/jnci/92.12.971.
- 17. Oestreicher N., White E., Lehman C.D. et al. (2002) Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res. Treat., 76(1): 73–81.
- 18. Myers E.R., Moorman P., Gierisch J.M. et al. (2015) Benefits and Harms of Breast Cancer Screening: A Systematic Review. Jama, 314(15): 1615–1634.
- 19. Nelson H.D., Pappas M., Cantor A. et al. (2016) Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann. Intern. Med., 164(4): 256–267. doi.org/10.7326/m15-0970.
- 20. Bjurstam N.G., Björneld L.M., Duffy S.W. (2016) Updated results of the Gothenburg Trial of Mammographic Screening. Cancer, 122(12): 1832–1835.
- 21. Nyström L., Andersson I., Bjurstam N. et al. (2002) Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet, 359(9310): 909–919. doi.org/10.1016/s0140-6736(02)08020-0.
- 22. Tabar L., Duffy S.W., Yen M.F. et al. (2002) All-cause mortality among breast cancer patients in a screening trial: Support for breast cancer mortality as an end point. J. Med. Screen., 9(4): 159–162. doi.org/10.1136/jms.9.4.159.
- 23. Howlader N., Noone A.-M., Krapcho M. et al. (2014) SEER Cancer Statistics Review, 1975–2012; National Cancer Institute: Bethesda, MD, USA.
- 24. Breast Cancer Surveillance Consortium. Performance Measures for 1,838,372 Screening Mammography Examinations from 2004 to 2008 by Age-Based on BCSC Data through 2009.
- 25. Sima C.S., Panageas K.S., Schrag D. (2010) Cancer screening among patients with advanced cancer. Jama, 304(14): 1584–1591. doi.org/10.1001/jama.2010.1449.
- 26. Miglioretti D.L., Lange J., van den Broek J.J. et al. (2016) Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. Ann. Intern. Med., 164(4): 205–214. doi.org/10.7326/m15-1241.
- 27. Sankaranarayanan R., Ramadas K., Thara S. et al. (2011) Clinical breast examination: Preliminary results from a cluster randomized controlled trial in India. J. Natl. Cancer Inst., 103(19): 1476–1480. doi.org/10.1093/jnci/djr304.
- 28. Brem R.F., Tabár L., Duffy S.W. et al. (2015) Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: The SomoInsight Study. Radiology, 274(3): 663–673.
- 29. Giuliano V., Giuliano C. (2013) Improved breast cancer detection in asymptomatic women using 3D-automated breast ultrasound in mammographically dense breasts. Clin. Imaging, 37(3): 480–486. DOI: 10.1016/j.clinimag.2012.09.018.
- 30. Kelly K.M., Dean J., Comulada W.S., Lee S.J. (2010) Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. Eur. Radiol., 20(3): 734–742. doi.org/10.1007/s00330-009-1588-y.
- 31. Melnikow J., Fenton J.J., Whitlock E.P. et al. (2016) Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. In Supplemental Screening for Breast Cancer in Women with Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force. Agency for Healthcare Research and Quality (US).
- 32. Monticciolo D.L., Newell M.S., Moy L. et al. (2018) Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR. J. Am. Coll. Radiol., 15(3): 408–414. doi.org/10.1016/j.jacr.2017.11.034.
- 33. Laws A., Katlin F., Hans M. et al. (2023) Screening MRI Does Not Increase Cancer Detection or Result in an Earlier Stage at Diagnosis for Patients with High-Risk Breast Lesions: A Propensity Score Analysis. Ann. Surg. Oncol., 30(1): 68–77.
- 34. Warner E., Messersmith H., Causer P. et al. (2008) Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann. Intern. Med., 148(9): 671–679.
|